From Wikipedia, the free encyclopedia

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.


Bibliography

Edit this section to compile the bibliography for your Wikipedia assignment. Add the name and/or notes about what each source covers, then use the "Cite" button to generate the citation for that source.

  • Baghban, R., Roshangar, L., Jahanban-Esfahlan, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18, 59 (2020). https://doi.org/10.1186/s12964-020-0530-4 [1]
  • Sterner, R.C., Sterner, R.M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021). https://doi.org/10.1038/s41408-021-00459-7 [2]
  • Bai R, Cui J. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. Front Immunol. 2022 Jun 27;13:890166. doi: 10.3389/fimmu.2022.890166. Erratum in: Front Immunol. 2022 Aug 11;13:1004587. PMID: 35833121; PMCID: PMC9271663. [3]
  • Murciano-Goroff, Y.R., Warner, A.B. & Wolchok, J.D. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res 30, 507–519 (2020). https://doi.org/10.1038/s41422-020-0337-2 [4]

References

  1. ^ Baghban, Roghayyeh; Roshangar, Leila; Jahanban-Esfahlan, Rana; Seidi, Khaled; Ebrahimi-Kalan, Abbas; Jaymand, Mehdi; Kolahian, Saeed; Javaheri, Tahereh; Zare, Peyman (2020-12). "Tumor microenvironment complexity and therapeutic implications at a glance". Cell Communication and Signaling. 18 (1). doi: 10.1186/s12964-020-0530-4. ISSN  1478-811X. PMC  7140346. PMID  32264958. {{ cite journal}}: Check date values in: |date= ( help)CS1 maint: PMC format ( link) CS1 maint: unflagged free DOI ( link)
  2. ^ Sterner, Robert C.; Sterner, Rosalie M. (2021-04-06). "CAR-T cell therapy: current limitations and potential strategies". Blood Cancer Journal. 11 (4). doi: 10.1038/s41408-021-00459-7. ISSN  2044-5385. PMC  8024391. PMID  33824268.{{ cite journal}}: CS1 maint: PMC format ( link)
  3. ^ Bai, Rilan; Cui, Jiuwei (2022-06-27). "Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing". Frontiers in Immunology. 13. doi: 10.3389/fimmu.2022.890166. ISSN  1664-3224.{{ cite journal}}: CS1 maint: unflagged free DOI ( link)
  4. ^ Murciano-Goroff, Yonina R.; Warner, Allison Betof; Wolchok, Jedd D. (2020-06). "The future of cancer immunotherapy: microenvironment-targeting combinations". Cell Research. 30 (6): 507–519. doi: 10.1038/s41422-020-0337-2. ISSN  1001-0602. PMC  7264181. PMID  32467593. {{ cite journal}}: Check date values in: |date= ( help)CS1 maint: PMC format ( link)

Outline of proposed changes

Click on the edit button to draft your outline.

  1. Updating new therapeutic drugs or immunotherapies developed in recent years targeting the tumor microenvironment using the resources I've just added.
From Wikipedia, the free encyclopedia

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.


Bibliography

Edit this section to compile the bibliography for your Wikipedia assignment. Add the name and/or notes about what each source covers, then use the "Cite" button to generate the citation for that source.

  • Baghban, R., Roshangar, L., Jahanban-Esfahlan, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18, 59 (2020). https://doi.org/10.1186/s12964-020-0530-4 [1]
  • Sterner, R.C., Sterner, R.M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021). https://doi.org/10.1038/s41408-021-00459-7 [2]
  • Bai R, Cui J. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. Front Immunol. 2022 Jun 27;13:890166. doi: 10.3389/fimmu.2022.890166. Erratum in: Front Immunol. 2022 Aug 11;13:1004587. PMID: 35833121; PMCID: PMC9271663. [3]
  • Murciano-Goroff, Y.R., Warner, A.B. & Wolchok, J.D. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res 30, 507–519 (2020). https://doi.org/10.1038/s41422-020-0337-2 [4]

References

  1. ^ Baghban, Roghayyeh; Roshangar, Leila; Jahanban-Esfahlan, Rana; Seidi, Khaled; Ebrahimi-Kalan, Abbas; Jaymand, Mehdi; Kolahian, Saeed; Javaheri, Tahereh; Zare, Peyman (2020-12). "Tumor microenvironment complexity and therapeutic implications at a glance". Cell Communication and Signaling. 18 (1). doi: 10.1186/s12964-020-0530-4. ISSN  1478-811X. PMC  7140346. PMID  32264958. {{ cite journal}}: Check date values in: |date= ( help)CS1 maint: PMC format ( link) CS1 maint: unflagged free DOI ( link)
  2. ^ Sterner, Robert C.; Sterner, Rosalie M. (2021-04-06). "CAR-T cell therapy: current limitations and potential strategies". Blood Cancer Journal. 11 (4). doi: 10.1038/s41408-021-00459-7. ISSN  2044-5385. PMC  8024391. PMID  33824268.{{ cite journal}}: CS1 maint: PMC format ( link)
  3. ^ Bai, Rilan; Cui, Jiuwei (2022-06-27). "Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing". Frontiers in Immunology. 13. doi: 10.3389/fimmu.2022.890166. ISSN  1664-3224.{{ cite journal}}: CS1 maint: unflagged free DOI ( link)
  4. ^ Murciano-Goroff, Yonina R.; Warner, Allison Betof; Wolchok, Jedd D. (2020-06). "The future of cancer immunotherapy: microenvironment-targeting combinations". Cell Research. 30 (6): 507–519. doi: 10.1038/s41422-020-0337-2. ISSN  1001-0602. PMC  7264181. PMID  32467593. {{ cite journal}}: Check date values in: |date= ( help)CS1 maint: PMC format ( link)

Outline of proposed changes

Click on the edit button to draft your outline.

  1. Updating new therapeutic drugs or immunotherapies developed in recent years targeting the tumor microenvironment using the resources I've just added.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook